Pleural Mesothelioma Treatment
MPM is a disease which attacks the lung pleura, or lining of the lungs. Serous membranes surround the lungs, and mesothelioma is a form of cancer that invades those membranes. Other serous membranes can be affected as well including those enclosing the abdomen and heart. The word lung cancer refers specifically to cancers that are born in the lung area.
One differentiation separating asbestosis and pleural mesothelioma since the former is not a cancer and the latter is. Asbestosis first develops in the lungs and is triggered by breathing in asbestos fibers that come to be set in the pleura. Malignant pleural mesothelioma cancer accounts for roughly 75 percent of all mesothelioma cases.
Chest pains and shortness of breath are common symptoms, but the pain can appear in other parts of the body.The detection often occurs when the progressing tumors enlarge the pleural area, inducing pain as it fills with fluid. This is referred to as pleural effusion.
Getting Tested
The standard course of action for someone suspected of peritoneal mesothelioma includes noninvasive lab tests, serum tumor markers, X-rays, and computed tomography (CT) scans of the appropriate areas. Markers are substances typically discovered in the blood or urine that reveal themselves as reactions to cancer cells. The presence, transformation, and change in quantity of these substances are assessed to aid in the discovery of cancer and assessment of cancer treatments. Over 80% of all cases of MPM will exhibit an enlarged pleural area in chest X-rays.
Pulmonary function tests are employed to determine the ability of the lungs to inhale, exhale, and transfer oxygen into the bloodstream. Patients with MPM usually exhibit restrictive breathing patterns and reduced oxygen transfer.
Swift and accurate diagnosis of MPM is critical in order to differentiate it from adenocarcinoma, a cancer that first develops in tissues of the glands. In some cases , a sample must be taken by fine needle removal from the tumor, especially if there is no apparent effusion.
A Computed Tomography scan provides additional contrast and sensitivity to identify the existence of pleural expansion, tumors, enlargement of the lymph nodes, and verification of asbestos exposure. If surgery is under review, magnetic resonance imaging can measure the extent of the growth within parts of the body such as the diaphragm and ribs. It can also assist in the development and process of localized radiotherapy.
Recent Advances
(PET) is an imaging technique to spot chest involvement and migration of the cancer to other parts of the body. Positron emission tomography is nuclear-based and uses small amounts of radioactive material to facilitate diagnosis and treatment, and has the ability to differentiate malignant pleural masses from benign masses.
In the instance that noninvasive tests are not conclusive, thoracoscopy is valuable in determining the nature and extent of pleural and lung lesions. Thoracoscopy can be used to help in surgical procedures as well as visualization of the impacted area. Termed VATS, video-assisted thoracoscopic surgery bears a small danger of circulating a tumor along the incisions and chest tube tracts. Invasive tests such as colonoscopy and endoscopy are commonly needed to remove colon and stomach cancer.
